Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||||||
---|---|---|---|---|---|---|---|---|---|
First Received Date † | June 9, 2006 | ||||||||
Last Updated Date | March 14, 2007 | ||||||||
Start Date † | April 2006 | ||||||||
Current Primary Outcome Measures † | |||||||||
Original Primary Outcome Measures † | |||||||||
Change History | Complete list of historical versions of study NCT00336271 on ClinicalTrials.gov Archive Site | ||||||||
Current Secondary Outcome Measures † | |||||||||
Original Secondary Outcome Measures † | |||||||||
Descriptive Information | |||||||||
Brief Title † | The Effects of Coffee | ||||||||
Official Title † | The Effects of Coffee | ||||||||
Brief Summary | In this study, participants will be eligible to participate in a paid research study that will examine the effects of regular coffee drinking. The study takes approximately 2 hours total, 55 min. on 2 separate days. Participants will be asked to do computer tasks and drink only coffee provided to them during the study. |
||||||||
Detailed Description | The purpose of the experiment is to evaluate how coffee affects different individuals while completing computer tasks. If an individual agrees to participate, particpants will be asked to come to the laboratory to drink coffee on 2 days. During each visit, participants will be asked to drink coffee, complete forms, and perform computer tasks. To be eligible to participate, participants must be medically healthy. |
||||||||
Study Phase | Phase I | ||||||||
Study Type † | Observational | ||||||||
Study Design † | Psychosocial, Cross-Sectional, Defined Population, Prospective Study | ||||||||
Condition † | Healthy Subjects | ||||||||
Intervention † | |||||||||
Study Arms / Comparison Groups | |||||||||
Publications * | |||||||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||||||
Recruitment Information | |||||||||
Recruitment Status † | Completed | ||||||||
Enrollment † | 50 | ||||||||
Completion Date | March 2007 | ||||||||
Primary Completion Date | |||||||||
Eligibility Criteria † | Inclusion Criteria:
For more information or to set up an appointment, please send a contact number (and a convenient time to call) via e-mail and a BPHP laboratory member will contact you or call the BPHP laboratory at the number listed below. |
||||||||
Gender | Both | ||||||||
Ages | 18 Years to 65 Years | ||||||||
Accepts Healthy Volunteers | Yes | ||||||||
Contacts †† | |||||||||
Location Countries † | United States | ||||||||
Expanded Access Status | |||||||||
Administrative Information | |||||||||
NCT ID † | NCT00336271 | ||||||||
Responsible Party | |||||||||
Secondary IDs †† | |||||||||
Study Sponsor † | American University | ||||||||
Collaborators †† | |||||||||
Investigators † |
|
||||||||
Information Provided By | American University | ||||||||
Verification Date | March 2007 | ||||||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |